﻿{"id":332,"date":"2009-03-01T00:00:01","date_gmt":"2009-03-01T00:00:01","guid":{"rendered":"https:\/\/awge.doctime.es\/?p=332"},"modified":"2016-05-24T08:22:06","modified_gmt":"2016-05-24T06:22:06","slug":"awge-101","status":"publish","type":"post","link":"https:\/\/awge.doctime.es\/index.php\/2009\/03\/01\/awge-101\/","title":{"rendered":"Safety and Usefulness of Intravenous Iron Sucrose in the Management of Preoperative Anemia in Patients with Menorrhagia: A Phase IV, Open-Label, Prospective, Randomized Study."},"content":{"rendered":"<div class='editorialPost'><strong>Editorial: Acta Haematol<\/strong><\/div>\n<div class='fechaPost'>Fecha: 01\/03\/2009<\/div>\n<div class='autorPost'>Kim YH, Chung HH, Kang SB, Kim SC, Kim YT<\/div>\n<div class='enlacePost'><a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19332985' target='_blank'>Acceso al enlace publicador<\/a><\/div>\n<hr>\n<\/hr>\n<div class='resumenPost'>The aim of this study was to compare the efficacy, safety and achievement of the target hemoglobin level (Hb >\/=10 g\/dl) in patients with preoperative anemia due to menorrhagia who received intravenous iron sucrose compared with oral iron protein succinylate for anemia management. Methods: Seventy-six patients with Hb levels <9.0 g\/dl who were scheduled to undergo surgical treatment were randomized to receive either intravenous iron sucrose (based on the calculated total iron deficit divided into 2 ampoule infusions intravenously 3 times a week, beginning 3 weeks before surgery) or oral iron (80 mg\/day of oral iron protein succinylate daily). Results: The intravenous iron group had higher increases in Hb (3.0 vs. 0.8 g\/dl; p < 0.0001) and ferritin levels (170.1 vs. 4.1 mug\/l; p < 0.0001) than the oral iron group. Achieving the target Hb was also higher in the intravenous iron group than in the oral iron group (76.7 vs. 11.5%; p < 0.0001). There were tolerable adverse events in both groups. Conclusion: Preoperative intravenous iron sucrose administration is more effective than oral iron and is as safe as oral iron therapy in the correction of preoperative anemia due to menorrhagia\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Editorial: Acta Haematol Fecha: 01\/03\/2009 Kim YH, Chung HH, Kang SB, Kim SC, Kim YT Acceso al enlace publicador The<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/332"}],"collection":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/comments?post=332"}],"version-history":[{"count":1,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/332\/revisions"}],"predecessor-version":[{"id":717,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/332\/revisions\/717"}],"wp:attachment":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/media?parent=332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/categories?post=332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/tags?post=332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}